ONCOTYPE DXX Trademark

Trademark Overview


On Wednesday, October 2, 2019, a trademark application was filed for ONCOTYPE DXX with the United States Patent and Trademark Office. The USPTO has given the ONCOTYPE DXX trademark a serial number of 88639660. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 15, 2021. This trademark is owned by Genomic Health, Inc.. The ONCOTYPE DXX trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Assays for testing tissue samples and bodily fluids for scientific research in the field of cancer detection, analysis and prognosis; diagnostic assays for testing tissue samples and bodily fluids for scientific research in the field of cancer detection, analysis and prognosis; clinical diagnostic reagents; reagents for scientific or medical research use, namely, reagents for use in preparation of RNA samples; kits consisting primarily of enzymes for scientific and research purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing; diagnostic kits comprised primarily of diagnostic reagents for clinical or medical laboratory use and diagnostic assays for testing tissue samples and bodily fluids for clinical or medical laboratory use in cancer detection, analysis and prognosis; diagnostic kits comprised primarily of enzymes for scientific and research purposes, and also including nucleic acids, buffers, reagents and assays for use in disease test...

Diagnostic kits comprised of medical diagnostic reagents and diagnostic assays for testing tissue samples and bodily fluids for use in cancer detection, analysis and prognosis; medical reagents; medical diagnostic reagents; kits for medical diagnostic purposes consisting primarily of enzymes for medical purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing and classification; diagnostic kits consisting primarily of enzymes for medical purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing and classification; medical diagnostic assays for testing of bodily fluids and tissue samples for use in disease detection and testing for medical and prognostic purposes; medical diagnostic reagents and assays for testing bodily fluids and tissue samples for use in disease testing and classification; enzyme preparations for medical purposes; biological preparations for the detection, diagnosis and monitoring of...

Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical testing services and information in the field of cancer research and disease classification

Medical testing for diagnostic and prognostic purposes in the field of cancer and disease classification; providing medical information to medical professionals in the form of reports in the field of cancer and disease classification
oncotype dxx

General Information


Serial Number88639660
Word MarkONCOTYPE DXX
Filing DateWednesday, October 2, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 15, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 19, 2020

Trademark Statements


Goods and ServicesAssays for testing tissue samples and bodily fluids for scientific research in the field of cancer detection, analysis and prognosis; diagnostic assays for testing tissue samples and bodily fluids for scientific research in the field of cancer detection, analysis and prognosis; clinical diagnostic reagents; reagents for scientific or medical research use, namely, reagents for use in preparation of RNA samples; kits consisting primarily of enzymes for scientific and research purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing; diagnostic kits comprised primarily of diagnostic reagents for clinical or medical laboratory use and diagnostic assays for testing tissue samples and bodily fluids for clinical or medical laboratory use in cancer detection, analysis and prognosis; diagnostic kits comprised primarily of enzymes for scientific and research purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing; clinical diagnostic reagents
Goods and ServicesDiagnostic kits comprised of medical diagnostic reagents and diagnostic assays for testing tissue samples and bodily fluids for use in cancer detection, analysis and prognosis; medical reagents; medical diagnostic reagents; kits for medical diagnostic purposes consisting primarily of enzymes for medical purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing and classification; diagnostic kits consisting primarily of enzymes for medical purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing and classification; medical diagnostic assays for testing of bodily fluids and tissue samples for use in disease detection and testing for medical and prognostic purposes; medical diagnostic reagents and assays for testing bodily fluids and tissue samples for use in disease testing and classification; enzyme preparations for medical purposes; biological preparations for the detection, diagnosis and monitoring of cancer for medical purposes; preparations for detecting genetic predispositions for medical purposes; biological preparations for use in the diagnosis, analysis and prognosis of cancer for medical purposes; diagnostic agents, preparations and substances for medical purposes
Goods and ServicesProviding laboratory research services in the field of gene expression, namely, cancer biology; Providing medical testing services and information in the field of cancer research and disease classification
Goods and ServicesMedical testing for diagnostic and prognostic purposes in the field of cancer and disease classification; providing medical information to medical professionals in the form of reports in the field of cancer and disease classification
Pseudo MarkONCO TYPE DXX

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSunday, October 6, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, October 6, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, October 6, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, October 6, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenomic Health, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Party NameGenomic Health, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Trademark Events


Event DateEvent Description
Tuesday, February 16, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 15, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 19, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 19, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 19, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 19, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 19, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 19, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 14, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 14, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 9, 2020ASSIGNED TO LIE
Wednesday, April 1, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 18, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 18, 2019NON-FINAL ACTION E-MAILED
Monday, November 18, 2019NON-FINAL ACTION WRITTEN
Monday, November 11, 2019ASSIGNED TO EXAMINER
Sunday, October 6, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, October 5, 2019NEW APPLICATION ENTERED IN TRAM